35:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
seCOnDAry CAuses :@0.076191:0.087639:0.266892:0.087639:0.266892:0.067474:0.076191:0.067474:0.009609:0.009609:0.014413:0.015522:0.013674:0.012935:0.013674:0.010718:0.011457:0.005174:0.014413:0.013674:0.011826:0.009609:0.009609:0.009609:0.005174
Table 2 lists the  common causes of secondary hyper-:@0.076190:0.103719:0.480942:0.103719:0.480942:0.087937:0.076190:0.087937:0.006441:0.010326:0.010311:0.003024:0.009827:0.006471:0.008376:0.006471:0.003024:0.003024:0.005866:0.005125:0.005866:0.006471:0.005125:0.009223:0.009827:0.004188:0.002268:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.006456:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.006471:0.009903:0.004747:0.006456:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.006456:0.009223:0.008104:0.010311:0.009827:0.004551:0.005020
tension, and very rare causes of secondary hypertension :@0.076190:0.118013:0.485145:0.118013:0.485145:0.102230:0.076190:0.102230:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.002948:0.010326:0.009223:0.010357:0.002963:0.008376:0.009827:0.004551:0.008104:0.002963:0.004551:0.010326:0.004551:0.009827:0.002948:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.002963:0.009903:0.004747:0.002963:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.002963:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188
have not been included. secondary causes should be :@0.076190:0.132306:0.485145:0.132306:0.485145:0.116523:0.076190:0.116523:0.009223:0.010326:0.008376:0.009827:0.005201:0.009223:0.009903:0.005125:0.005201:0.010311:0.009827:0.009827:0.009223:0.005201:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.010357:0.004188:0.005216:0.007529:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.005201:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.005216:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005201:0.010311:0.009827:0.004188
considered  based  on  a  detailed history  of  symptoms, :@0.076190:0.146599:0.485115:0.146599:0.485115:0.130816:0.076190:0.130816:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004188:0.002359:0.010311:0.010326:0.005866:0.009827:0.010357:0.004188:0.002359:0.009903:0.009223:0.004188:0.002359:0.010326:0.004188:0.002359:0.010357:0.009827:0.005125:0.010326:0.003024:0.003024:0.009827:0.010357:0.006562:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.002359:0.009903:0.004747:0.004188:0.002359:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.004188
examination and special investigations. This should not :@0.076190:0.160892:0.485130:0.160892:0.485130:0.145110:0.076190:0.145110:0.009827:0.007257:0.010326:0.014182:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005428:0.010326:0.009223:0.010357:0.005428:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.005443:0.003024:0.009223:0.008376:0.009827:0.005866:0.005125:0.003024:0.010175:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005428:0.006441:0.009223:0.003024:0.005866:0.005428:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005428:0.009223:0.009903:0.005125:0.004188
be  embarked  on  in  the  first  instance  unless  there  is  a :@0.076190:0.175186:0.485130:0.175186:0.485130:0.159403:0.076190:0.159403:0.010311:0.009827:0.004188:0.002419:0.009827:0.014182:0.010311:0.010326:0.004551:0.007590:0.009827:0.010357:0.004188:0.002419:0.009903:0.009223:0.004188:0.002419:0.003024:0.009223:0.004188:0.002419:0.005125:0.009223:0.009827:0.004188:0.002404:0.003681:0.003681:0.004551:0.005866:0.005125:0.004188:0.002404:0.003024:0.009223:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.004188:0.002419:0.009192:0.009223:0.003024:0.009827:0.005866:0.005866:0.004188:0.002419:0.005125:0.009223:0.009827:0.004551:0.009827:0.004188:0.002404:0.003024:0.005866:0.004188:0.002419:0.010326:0.004188
strong clinical suspicion. The most common causes are :@0.076190:0.189479:0.485130:0.189479:0.485130:0.173696:0.076190:0.173696:0.005866:0.005125:0.004551:0.009903:0.009223:0.010175:0.004989:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.005020:0.005866:0.009192:0.005866:0.010311:0.003024:0.009782:0.003024:0.009903:0.009223:0.004188:0.005004:0.006441:0.009223:0.009827:0.005004:0.014182:0.009903:0.005866:0.005125:0.005004:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004989:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.005004:0.010326:0.004551:0.009827:0.004188
primary aldosteronism, CKD, and sleep apnoea. In RH, :@0.076190:0.203772:0.485130:0.203772:0.485130:0.187990:0.076190:0.187990:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.005503:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.003024:0.005866:0.014182:0.004188:0.005488:0.012292:0.008935:0.011249:0.004188:0.005488:0.010326:0.009223:0.010357:0.005503:0.005866:0.003024:0.009827:0.009827:0.010311:0.005503:0.010326:0.010311:0.009223:0.009903:0.009827:0.010326:0.004188:0.005488:0.003417:0.009223:0.005503:0.009177:0.010326:0.004188:0.004188
up to 20% of patients may have primary aldosteronism :@0.076190:0.218065:0.485145:0.218065:0.485145:0.202283:0.076190:0.202283:0.009192:0.010311:0.005216:0.005125:0.009903:0.005201:0.008376:0.008376:0.011717:0.005216:0.009903:0.004747:0.005201:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005216:0.014182:0.010326:0.008104:0.005216:0.009223:0.010326:0.008376:0.009827:0.005216:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.005216:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.003024:0.005866:0.014182:0.004188
and it is worthwhile performing an aldosterone-to-renin :@0.076190:0.232359:0.485145:0.232359:0.485145:0.216576:0.076190:0.216576:0.010326:0.009223:0.010357:0.004989:0.003024:0.005125:0.004989:0.003024:0.005866:0.004989:0.012564:0.009903:0.004551:0.005125:0.009223:0.012564:0.009223:0.003024:0.003024:0.009827:0.004974:0.010311:0.009827:0.004551:0.004747:0.009903:0.004551:0.014182:0.003024:0.009207:0.010175:0.004989:0.010326:0.009223:0.004989:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.005020:0.005125:0.009903:0.005020:0.004551:0.009827:0.009223:0.003024:0.009223:0.004188
ratio even if the potassium is normal. This test will also :@0.076190:0.246652:0.485115:0.246652:0.485115:0.230869:0.076190:0.230869:0.004551:0.010326:0.005125:0.003024:0.009903:0.006320:0.009827:0.008376:0.009827:0.009223:0.006320:0.003024:0.004747:0.006335:0.005125:0.009223:0.009827:0.006320:0.010311:0.009903:0.005125:0.010326:0.005866:0.005866:0.003024:0.009192:0.014182:0.006335:0.003024:0.005866:0.006335:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004188:0.006320:0.006441:0.009223:0.003024:0.005866:0.006335:0.005125:0.009827:0.005866:0.005125:0.006320:0.012564:0.003024:0.003024:0.003024:0.006335:0.010326:0.003024:0.005866:0.009903:0.004188
identify patients with Liddle phenotype where both the :@0.076190:0.260945:0.485160:0.260945:0.485160:0.245163:0.076190:0.245163:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.004747:0.008104:0.004642:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004642:0.012564:0.003024:0.005125:0.009223:0.004626:0.006985:0.003024:0.010357:0.010357:0.003024:0.009827:0.004642:0.010311:0.009223:0.009827:0.009223:0.009903:0.005125:0.008104:0.010311:0.009827:0.004626:0.012564:0.009223:0.009827:0.004551:0.009827:0.004626:0.010311:0.009903:0.005125:0.009223:0.004626:0.005125:0.009223:0.009827:0.004188
aldosterone  and renin are suppressed.  primary aldo-:@0.076190:0.275238:0.480942:0.275238:0.480942:0.259456:0.076190:0.259456:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004188:0.003780:0.010326:0.009223:0.010357:0.007983:0.004551:0.009827:0.009223:0.003024:0.009223:0.007983:0.010326:0.004551:0.009827:0.007983:0.005866:0.009192:0.010311:0.010311:0.004551:0.009827:0.005866:0.005866:0.009827:0.010357:0.004188:0.004188:0.003795:0.008950:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.007983:0.010326:0.003024:0.010357:0.009903:0.005020
steronism will respond to spironolactone or adrenalecto-:@0.076190:0.289532:0.480972:0.289532:0.480972:0.273749:0.076190:0.273749:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.003024:0.005866:0.014182:0.003130:0.012564:0.003024:0.003024:0.003024:0.003145:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.003130:0.005125:0.009903:0.003130:0.005866:0.010311:0.003024:0.004551:0.009903:0.009223:0.009903:0.003024:0.010326:0.009782:0.005125:0.009903:0.009223:0.009827:0.003115:0.009903:0.004551:0.003130:0.010326:0.010357:0.004551:0.009827:0.009223:0.010326:0.003024:0.009827:0.009782:0.005125:0.009903:0.005020
my if an adenoma is identified, while a Liddle syndrome :@0.076190:0.303825:0.485130:0.303825:0.485130:0.288042:0.076190:0.288042:0.014182:0.008104:0.004022:0.003024:0.004747:0.004022:0.010326:0.009223:0.004022:0.010326:0.010357:0.009827:0.009223:0.009903:0.014182:0.010326:0.004022:0.003024:0.005866:0.004037:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188:0.004022:0.012564:0.009223:0.003024:0.003024:0.009827:0.004022:0.010326:0.004022:0.006985:0.003024:0.010357:0.010357:0.003024:0.009827:0.004037:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188
will respond to amiloride. Unfortunately, pure amiloride :@0.076190:0.318118:0.485145:0.318118:0.485145:0.302336:0.076190:0.302336:0.012564:0.003024:0.003024:0.003024:0.005201:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.005186:0.005125:0.009903:0.005186:0.010326:0.014182:0.003024:0.003024:0.009903:0.004551:0.003024:0.010357:0.009827:0.004188:0.005186:0.009903:0.009223:0.004747:0.009888:0.004551:0.005125:0.009192:0.009223:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.005171:0.010311:0.009192:0.004551:0.009827:0.005186:0.010326:0.014182:0.003024:0.003024:0.009903:0.004551:0.003024:0.010357:0.009827:0.004188
is not registered in south Africa, and it is suggested the :@0.076190:0.332412:0.485130:0.332412:0.485130:0.316629:0.076190:0.316629:0.003024:0.005866:0.005004:0.009223:0.009903:0.005125:0.004989:0.004551:0.009827:0.010175:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.004989:0.003024:0.009223:0.004989:0.007529:0.009903:0.009192:0.005125:0.009223:0.004989:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.004989:0.010326:0.009223:0.010357:0.004989:0.003024:0.005125:0.004989:0.003024:0.005866:0.005004:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.009827:0.010357:0.004989:0.005125:0.009223:0.009827:0.004188
practitioner try half-dose amiloride complex with a thia-:@0.076190:0.346705:0.480957:0.346705:0.480957:0.330922:0.076190:0.330922:0.010311:0.004551:0.010326:0.009782:0.005125:0.003024:0.005125:0.003024:0.009903:0.009223:0.009827:0.004551:0.004052:0.005125:0.004551:0.008104:0.004052:0.009223:0.010326:0.003024:0.004747:0.005020:0.010357:0.009903:0.005866:0.009827:0.004067:0.010326:0.014182:0.003024:0.003024:0.009903:0.004551:0.003024:0.010357:0.009827:0.004067:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.007257:0.004067:0.012564:0.003024:0.005125:0.009223:0.004067:0.010326:0.004067:0.005125:0.009223:0.003024:0.010326:0.005020
zide in patients with low renin/aldosterone and RH.:@0.076190:0.360998:0.445624:0.360998:0.445624:0.345215:0.076190:0.345215:0.006426:0.003024:0.010357:0.009827:0.004188:0.003024:0.009223:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.003024:0.009903:0.012564:0.004188:0.004551:0.009827:0.009223:0.003024:0.009223:0.006607:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.009177:0.010326:0.004188
some authorities consider routinely screening patients :@0.090478:0.375291:0.485130:0.375291:0.485130:0.359509:0.090478:0.359509:0.007529:0.009903:0.014182:0.009827:0.003810:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.003024:0.005125:0.003024:0.009827:0.005866:0.003795:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.003810:0.004551:0.009903:0.009192:0.005110:0.003024:0.009223:0.009827:0.003024:0.008104:0.003810:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.003795:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
for sleep apnoea in RH, but in the author’s experience a :@0.076190:0.389585:0.485145:0.389585:0.485145:0.373802:0.076190:0.373802:0.004747:0.009903:0.004551:0.003644:0.005866:0.003024:0.009827:0.009827:0.010311:0.003659:0.010326:0.010311:0.009223:0.009903:0.009827:0.010326:0.003659:0.003024:0.009223:0.003659:0.009177:0.010326:0.004188:0.003659:0.010311:0.009192:0.005125:0.003659:0.003024:0.009223:0.003659:0.005125:0.009223:0.009827:0.003644:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.005307:0.005866:0.003644:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.009827:0.009223:0.009782:0.009827:0.003644:0.010326:0.004188
positive test is rarely found if there are no clinical clues. :@0.076190:0.403878:0.485115:0.403878:0.485115:0.388095:0.076190:0.388095:0.010311:0.009903:0.005866:0.003024:0.005125:0.003024:0.008376:0.009827:0.004747:0.005125:0.009827:0.005866:0.005125:0.004732:0.003024:0.005866:0.004747:0.004551:0.010326:0.004551:0.009827:0.003024:0.008104:0.004747:0.004747:0.009903:0.009192:0.009223:0.010357:0.004732:0.003024:0.004747:0.004747:0.005125:0.009223:0.009827:0.004551:0.009827:0.004732:0.010326:0.004551:0.009827:0.004732:0.009223:0.009903:0.004732:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004747:0.009782:0.003024:0.009192:0.009827:0.005866:0.004188:0.004188
Always remember that apnoea may occur  in non-:@0.076190:0.418171:0.480957:0.418171:0.480957:0.402388:0.076190:0.402388:0.011188:0.003024:0.012564:0.010326:0.008104:0.005866:0.009328:0.004551:0.009827:0.014182:0.009827:0.014182:0.010311:0.009827:0.004551:0.009328:0.005125:0.009223:0.010326:0.005125:0.009328:0.010326:0.010311:0.009223:0.009903:0.009827:0.010326:0.009328:0.014182:0.010326:0.008104:0.009328:0.009903:0.009782:0.009782:0.009192:0.004551:0.004188:0.005125:0.003024:0.009223:0.009328:0.009223:0.009903:0.009223:0.005020
obese patients. :@0.076190:0.432464:0.193318:0.432464:0.193318:0.416682:0.076190:0.416682:0.009903:0.010311:0.009827:0.005866:0.009827:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004188
Renal artery stenosis (RAS) due to fibromuscular dys:@0.090478:0.446758:0.475907:0.446758:0.475907:0.430975:0.090478:0.430975:0.009177:0.009827:0.009223:0.010326:0.003024:0.005806:0.010326:0.004551:0.005125:0.009827:0.004551:0.008104:0.005806:0.005866:0.005125:0.009827:0.009223:0.009903:0.005866:0.003024:0.005866:0.005806:0.005579:0.009177:0.011188:0.007529:0.005579:0.005806:0.010357:0.009192:0.009827:0.005806:0.005125:0.009903:0.005806:0.003681:0.003681:0.010311:0.004551:0.009903:0.014182:0.009192:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005806:0.010357:0.008104:0.005866
-:@0.475907:0.446758:0.480927:0.446758:0.480927:0.430975:0.475907:0.430975:0.005020
plasia responds well to percutaneous renal artery dila-:@0.076190:0.461051:0.480957:0.461051:0.480957:0.445268:0.076190:0.445268:0.010311:0.003024:0.010326:0.005866:0.003024:0.010326:0.005473:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.005866:0.005458:0.012564:0.009827:0.003024:0.003024:0.005458:0.005125:0.009903:0.005458:0.010311:0.009827:0.004551:0.009782:0.009192:0.005125:0.010326:0.009223:0.009827:0.009903:0.009192:0.005866:0.005458:0.004551:0.009827:0.009223:0.010326:0.003024:0.005458:0.010326:0.004551:0.005125:0.009827:0.004551:0.008104:0.005443:0.010357:0.003024:0.003024:0.010326:0.005020
tation with up to 70%  cure rates. Takayasu’s  arteritis :@0.076190:0.475344:0.485145:0.475344:0.485145:0.459562:0.076190:0.459562:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.008134:0.012564:0.003024:0.005125:0.009223:0.008134:0.009192:0.010311:0.008134:0.005125:0.009903:0.008134:0.008376:0.008376:0.011717:0.004188:0.003961:0.009782:0.009192:0.004551:0.009827:0.008134:0.004551:0.010326:0.005125:0.009827:0.005866:0.004188:0.008134:0.006441:0.010326:0.007590:0.010326:0.008104:0.010326:0.005866:0.009192:0.005307:0.005866:0.004188:0.003961:0.010326:0.004551:0.005125:0.009827:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188
does not respond to renal artery dilatation or stenting, :@0.076190:0.489637:0.485160:0.489637:0.485160:0.473855:0.076190:0.473855:0.010357:0.009903:0.009827:0.005866:0.005549:0.009223:0.009903:0.005125:0.005549:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.005549:0.005125:0.009903:0.005549:0.004551:0.009827:0.009223:0.010326:0.003024:0.005549:0.010326:0.004551:0.005125:0.009827:0.004551:0.008104:0.005549:0.010357:0.003024:0.003024:0.010326:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005549:0.009903:0.004551:0.005549:0.005866:0.005125:0.009827:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188:0.004188
and good responses can be obtained by vascular re-:@0.076190:0.503931:0.480957:0.503931:0.480957:0.488148:0.076190:0.488148:0.010326:0.009223:0.010357:0.005806:0.010175:0.009903:0.009903:0.010357:0.005806:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.005866:0.005806:0.009782:0.010326:0.009223:0.005806:0.010311:0.009827:0.005806:0.009903:0.010311:0.005125:0.010326:0.003024:0.009223:0.009827:0.010357:0.005806:0.010311:0.008104:0.005806:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005821:0.004551:0.009827:0.005020
construction or transplanting the affected kidney to the :@0.076190:0.518224:0.485130:0.518224:0.485130:0.502441:0.076190:0.502441:0.009782:0.009903:0.009223:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.003961:0.009903:0.004551:0.003976:0.005125:0.004551:0.010326:0.009223:0.005866:0.010311:0.003024:0.010326:0.009223:0.005125:0.003024:0.009223:0.010175:0.003976:0.005125:0.009223:0.009827:0.003976:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.009827:0.010357:0.003976:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.003991:0.005125:0.009903:0.003976:0.005125:0.009223:0.009827:0.004188
iliac artery, for example. Results of percutaneous stent-:@0.076190:0.532517:0.480957:0.532517:0.480957:0.516735:0.076190:0.516735:0.003024:0.003024:0.003024:0.010326:0.009782:0.004974:0.010326:0.004551:0.005125:0.009827:0.004551:0.008104:0.004188:0.004959:0.004747:0.009903:0.004551:0.004959:0.009827:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.004188:0.004959:0.009177:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.004959:0.009903:0.004747:0.004959:0.010311:0.009827:0.004551:0.009782:0.009192:0.005125:0.010326:0.009223:0.009827:0.009903:0.009192:0.005866:0.004959:0.005866:0.005125:0.009827:0.009223:0.005125:0.005020
ing for  atherosclerotic  RAs  have been  disappointing :@0.076190:0.546811:0.485115:0.546811:0.485115:0.531028:0.076190:0.531028:0.003024:0.009223:0.010175:0.008104:0.004747:0.009903:0.004551:0.004188:0.003901:0.010326:0.005125:0.009223:0.009827:0.004551:0.009903:0.005851:0.009782:0.003024:0.009827:0.004551:0.009903:0.005125:0.003024:0.009782:0.004188:0.003901:0.009177:0.011188:0.007529:0.004188:0.003901:0.009223:0.010326:0.008376:0.009827:0.008104:0.010311:0.009827:0.009827:0.009223:0.004188:0.003901:0.010357:0.003024:0.005866:0.010326:0.010311:0.010311:0.009903:0.003024:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188
and this should be reserved for selected cases.  sleep :@0.076190:0.561104:0.485140:0.561259:0.485140:0.545476:0.076190:0.545321:0.010326:0.009223:0.010357:0.005836:0.005125:0.009223:0.003024:0.005866:0.005836:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005836:0.010311:0.009827:0.005836:0.004551:0.009827:0.005866:0.009827:0.004551:0.008376:0.009827:0.010357:0.005821:0.004747:0.009903:0.004551:0.005821:0.005866:0.009827:0.003024:0.009827:0.009782:0.005125:0.009827:0.010357:0.005836:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.004863:0.005836:0.007529:0.003024:0.009827:0.009827:0.010311:0.114257
9:@0.429738:0.555960:0.434596:0.555960:0.434596:0.546806:0.429738:0.546806:0.004858
apnoea responds well to nocturnal CpAp, but patient :@0.076186:0.575552:0.485140:0.575552:0.485140:0.559770:0.076186:0.559770:0.010326:0.010311:0.009223:0.009903:0.009827:0.010326:0.006002:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.005866:0.006002:0.012564:0.009827:0.003024:0.003024:0.006002:0.005125:0.009903:0.005987:0.009223:0.009903:0.009782:0.005125:0.009192:0.004551:0.009223:0.010326:0.003024:0.005987:0.012292:0.008950:0.011188:0.008950:0.004188:0.005987:0.010311:0.009192:0.005125:0.006002:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188
adherence  is problematical. Funding  from  medical :@0.076186:0.589845:0.485110:0.589845:0.485110:0.574063:0.076186:0.574063:0.010326:0.010357:0.009223:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.004188:0.006320:0.003024:0.005866:0.010523:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.010326:0.005125:0.003024:0.009782:0.010326:0.003024:0.004188:0.010523:0.007333:0.009192:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188:0.006320:0.004747:0.004551:0.009903:0.014182:0.004188:0.006320:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.004188
schemes and health authorities is also restricted despite :@0.076186:0.604139:0.485140:0.604139:0.485140:0.588356:0.076186:0.588356:0.005866:0.009782:0.009223:0.009827:0.014182:0.009827:0.005866:0.003991:0.010326:0.009223:0.010357:0.003991:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.003991:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.003024:0.005125:0.003024:0.009827:0.005866:0.003991:0.003024:0.005866:0.004007:0.010326:0.003024:0.005866:0.009903:0.004007:0.004551:0.009827:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.009827:0.010357:0.003991:0.010357:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.004188
hypertension being a prescribed minimum benefit.:@0.076186:0.618432:0.445498:0.618432:0.445498:0.602649:0.076186:0.602649:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.010311:0.009827:0.003024:0.009223:0.010175:0.004188:0.010326:0.004188:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.004188:0.014182:0.003024:0.009223:0.003024:0.014182:0.009192:0.014182:0.004188:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188
patients with CKD often require four or more antihy-:@0.090473:0.632725:0.480937:0.632725:0.480937:0.616943:0.090473:0.616943:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006138:0.012564:0.003024:0.005125:0.009223:0.006153:0.012292:0.008935:0.011249:0.006138:0.009903:0.004747:0.005125:0.009827:0.009223:0.006138:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.006138:0.004747:0.009903:0.009192:0.004551:0.006138:0.009903:0.004551:0.006138:0.014182:0.009903:0.004551:0.009827:0.006138:0.010326:0.009223:0.005125:0.003024:0.009223:0.008104:0.005020
pertensive drugs, and if eGFR <45 ml/min, switching to :@0.076186:0.647018:0.485140:0.647018:0.485140:0.631236:0.076186:0.631236:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.005488:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.005488:0.010326:0.009223:0.010357:0.005488:0.003024:0.004747:0.005488:0.009827:0.013184:0.007333:0.009177:0.005488:0.009162:0.008376:0.008376:0.005488:0.014182:0.003024:0.006607:0.014182:0.003024:0.009223:0.004188:0.005488:0.005866:0.012564:0.003024:0.005125:0.009782:0.009223:0.003024:0.009223:0.010175:0.005488:0.005125:0.009903:0.004188
a loop diuretic is advised. High doses may also be re-:@0.519037:0.084905:0.923804:0.084905:0.923804:0.069123:0.519037:0.069123:0.010326:0.005942:0.003024:0.009903:0.009903:0.010311:0.005927:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005927:0.003024:0.005866:0.005942:0.010326:0.010357:0.008376:0.003024:0.005866:0.009827:0.010357:0.004188:0.005942:0.010326:0.003024:0.010175:0.009223:0.005927:0.010357:0.009903:0.005866:0.009827:0.005866:0.005942:0.014182:0.010326:0.008104:0.005942:0.010326:0.003024:0.005866:0.009903:0.005942:0.010311:0.009827:0.005942:0.004551:0.009827:0.005020
quired, especially if the CKD is stage 4 or 5.:@0.519037:0.099383:0.831321:0.099383:0.831321:0.083601:0.519037:0.083601:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.004188:0.004188:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188:0.003024:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.012292:0.008935:0.011249:0.004188:0.003024:0.005866:0.004188:0.005866:0.005125:0.010326:0.010175:0.009827:0.004188:0.008376:0.004188:0.009903:0.004551:0.004188:0.008376:0.004188
Other  forms  of  secondary  hypertension  need  to  be :@0.533325:0.113861:0.927977:0.113861:0.927977:0.098079:0.533325:0.098079:0.013138:0.005125:0.009223:0.009827:0.004551:0.004188:0.002691:0.004747:0.009903:0.004551:0.014182:0.005866:0.004188:0.002691:0.009903:0.004747:0.004188:0.002691:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.004188:0.002691:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.002691:0.009223:0.009827:0.009827:0.010357:0.004188:0.002691:0.005125:0.009903:0.004188:0.002691:0.010311:0.009827:0.004188
treated on their merits and are beyond the scope of :@0.519037:0.128339:0.927992:0.128339:0.927992:0.112557:0.519037:0.112557:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.006592:0.009903:0.009223:0.006592:0.005125:0.009223:0.009827:0.003024:0.004551:0.006592:0.014182:0.009827:0.004551:0.003024:0.005125:0.005866:0.006592:0.010326:0.009223:0.010357:0.006592:0.010326:0.004551:0.009827:0.006592:0.010311:0.009827:0.008104:0.009903:0.009223:0.010357:0.006592:0.005125:0.009223:0.009827:0.006592:0.005866:0.009782:0.009903:0.010311:0.009827:0.006592:0.009903:0.004747:0.004188
this article.:@0.519037:0.142817:0.596311:0.142817:0.596311:0.127035:0.519037:0.127035:0.005125:0.009223:0.003024:0.005866:0.004188:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.004188
PHArmACOlOGiCAl treAtment Of rH:@0.519047:0.176049:0.867558:0.176049:0.867558:0.155884:0.519047:0.155884:0.010348:0.012566:0.013674:0.010718:0.016631:0.013674:0.014413:0.015522:0.008131:0.015522:0.015522:0.005174:0.014413:0.013674:0.008131:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761:0.005174:0.015522:0.008870:0.005174:0.010718:0.012566
Further pharmacological treatment of RH needs to be :@0.519047:0.192301:0.927987:0.192301:0.927987:0.176518:0.519047:0.176518:0.007333:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.005609:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.005624:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005624:0.009903:0.004747:0.005624:0.009177:0.010326:0.005624:0.009223:0.009827:0.009827:0.010357:0.005866:0.005624:0.005125:0.009903:0.005624:0.010311:0.009827:0.004188
instituted only after consideration of the factors de-:@0.519047:0.206779:0.923814:0.206779:0.923814:0.190996:0.519047:0.190996:0.003024:0.009223:0.005866:0.005125:0.003024:0.005125:0.009192:0.005125:0.009827:0.010357:0.008512:0.009903:0.009223:0.003024:0.008104:0.008512:0.010326:0.004747:0.005125:0.009827:0.004551:0.008512:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.008512:0.009903:0.004747:0.008512:0.005125:0.009223:0.009827:0.008512:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.008512:0.010357:0.009827:0.005020
scribed above. Recent evidence suggests that the next :@0.519047:0.221257:0.928002:0.221257:0.928002:0.205474:0.519047:0.205474:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.003916:0.010326:0.010311:0.009903:0.008376:0.009827:0.004188:0.003916:0.009177:0.009827:0.009782:0.009827:0.009223:0.005125:0.003916:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.003916:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.005866:0.003916:0.005125:0.009223:0.010326:0.005125:0.003916:0.005125:0.009223:0.009827:0.003916:0.009223:0.009827:0.007257:0.005125:0.004188
step in treatment is the use of low-dose spironolactone :@0.519047:0.235735:0.928002:0.235735:0.928002:0.219952:0.519047:0.219952:0.005866:0.005125:0.009827:0.010311:0.004883:0.003024:0.009223:0.004883:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004868:0.003024:0.005866:0.004883:0.005125:0.009223:0.009827:0.004868:0.009192:0.005866:0.009827:0.004883:0.009903:0.004747:0.004868:0.003024:0.009903:0.012564:0.005020:0.010357:0.009903:0.005866:0.009827:0.004883:0.005866:0.010311:0.003024:0.004551:0.009903:0.009223:0.009903:0.003024:0.010326:0.009782:0.005125:0.009903:0.009223:0.009827:0.004188
(12.5 mg-25 mg) and that this is superior to beta- and :@0.519047:0.250213:0.928002:0.250213:0.928002:0.234430:0.519047:0.234430:0.005579:0.008376:0.008376:0.004188:0.008376:0.005927:0.014182:0.010175:0.005020:0.008376:0.008376:0.005927:0.014182:0.010175:0.005579:0.005927:0.010326:0.009223:0.010357:0.005912:0.005125:0.009223:0.010326:0.005125:0.005912:0.005125:0.009223:0.003024:0.005866:0.005927:0.003024:0.005866:0.005927:0.005866:0.009192:0.010311:0.009827:0.004551:0.003024:0.009903:0.004551:0.005912:0.005125:0.009903:0.005912:0.010311:0.009827:0.005125:0.010326:0.005020:0.005927:0.010326:0.009223:0.010357:0.004188
alpha  blockers.  Response is  predicted by a low re-:@0.519047:0.264691:0.923802:0.264671:0.923802:0.248888:0.519047:0.248908:0.010326:0.003024:0.010311:0.009223:0.010326:0.004188:0.003462:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.004188:0.009709:0.007635:0.009177:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.007635:0.003024:0.005866:0.004188:0.003462:0.010311:0.004551:0.009827:0.010357:0.003024:0.009782:0.005125:0.009827:0.010357:0.007635:0.010311:0.008104:0.007635:0.010326:0.007635:0.003024:0.009903:0.012564:0.007635:0.004551:0.009827:0.064816
10:@0.634940:0.259372:0.644656:0.259372:0.644656:0.250218:0.634940:0.250218:0.004858:0.004858
nin level and normal-to-high  aldosterone.   spirono-:@0.519050:0.279149:0.923817:0.279145:0.923817:0.263362:0.519050:0.263366:0.009223:0.003024:0.009223:0.010024:0.003024:0.009827:0.008376:0.009827:0.003024:0.010024:0.010326:0.009223:0.010357:0.010024:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.005020:0.005125:0.009903:0.005020:0.009223:0.003024:0.010175:0.009223:0.004188:0.005821:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004188:0.009706:0.004188:0.005836:0.007529:0.010311:0.003024:0.004551:0.009903:0.009223:0.009903:0.045847
11:@0.844610:0.273846:0.854326:0.273846:0.854326:0.264693:0.844610:0.264693:0.004858:0.004858
lactone should be avoided if the eGFR <45 ml/min or K+ :@0.519050:0.293623:0.927990:0.293623:0.927990:0.277840:0.519050:0.277840:0.003024:0.010326:0.009782:0.005125:0.009903:0.009223:0.009827:0.003750:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003750:0.010311:0.009827:0.003750:0.010326:0.008376:0.009903:0.003024:0.010357:0.009827:0.010357:0.003750:0.003024:0.004747:0.003750:0.005125:0.009223:0.009827:0.003750:0.009827:0.013184:0.007333:0.009177:0.003750:0.009162:0.008376:0.008376:0.003750:0.014182:0.003024:0.006607:0.014182:0.003024:0.009223:0.003750:0.009903:0.004551:0.003750:0.008935:0.009162:0.004188
>5 mmol/L. Monitoring of serum K+ is essential to detect :@0.519050:0.308101:0.928005:0.308101:0.928005:0.292318:0.519050:0.292318:0.009162:0.008376:0.004188:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.004188:0.004188:0.013894:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.004173:0.009903:0.004747:0.004188:0.005866:0.009827:0.004551:0.009192:0.014182:0.004188:0.008935:0.009162:0.004188:0.003024:0.005866:0.004188:0.009827:0.005866:0.005866:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.004188:0.005125:0.009903:0.004188:0.010357:0.009827:0.005125:0.009827:0.009782:0.005125:0.004188
occasional hyperkalaemia. :@0.519050:0.322579:0.723414:0.322579:0.723414:0.306796:0.519050:0.306796:0.009903:0.009782:0.009782:0.010326:0.005866:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188:0.009223:0.008104:0.010311:0.009827:0.004551:0.007590:0.010326:0.003024:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.004188
As these studies were done in largely European popu-:@0.533337:0.337057:0.923832:0.337057:0.923832:0.321274:0.533337:0.321274:0.010886:0.005564:0.005473:0.004823:0.008920:0.009525:0.005564:0.009525:0.005473:0.005564:0.004823:0.008890:0.010054:0.002721:0.009525:0.005564:0.005473:0.012262:0.009525:0.004248:0.009525:0.005473:0.010054:0.009601:0.008920:0.009525:0.005473:0.002721:0.008920:0.005473:0.002721:0.010024:0.004248:0.009873:0.009525:0.002721:0.007801:0.005473:0.007801:0.008890:0.004248:0.009601:0.010009:0.009525:0.010024:0.008920:0.005473:0.010009:0.009601:0.010009:0.008890:0.005020
lations and where the Liddle phenotype is rare, we have :@0.519050:0.351535:0.928050:0.351535:0.928050:0.335752:0.519050:0.335752:0.002721:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.004883:0.010024:0.008920:0.010054:0.004883:0.012262:0.008920:0.009525:0.004248:0.009525:0.004883:0.004823:0.008920:0.009525:0.004883:0.006683:0.002721:0.010054:0.010054:0.002721:0.009525:0.004883:0.010009:0.008920:0.009525:0.008920:0.009601:0.004823:0.007801:0.010009:0.009525:0.004883:0.002721:0.005564:0.004883:0.004248:0.010024:0.004248:0.009525:0.003886:0.004883:0.012262:0.009525:0.004883:0.008920:0.010024:0.008074:0.009827:0.004188
developed  an  alternative  approach  to  RH  in  Africa  by :@0.519050:0.366013:0.927959:0.366013:0.927959:0.350230:0.519050:0.350230:0.010054:0.009525:0.008074:0.009525:0.002721:0.009601:0.010009:0.009525:0.010054:0.004188:0.002570:0.010024:0.008920:0.004188:0.002570:0.010024:0.002721:0.004823:0.009525:0.004248:0.008920:0.010024:0.004823:0.002721:0.008074:0.009525:0.004188:0.002570:0.010024:0.010009:0.010009:0.004248:0.009601:0.010024:0.009480:0.008920:0.004188:0.002570:0.004823:0.009601:0.004188:0.002570:0.008875:0.010024:0.004188:0.002570:0.002721:0.008920:0.004188:0.002570:0.010886:0.004445:0.004248:0.002721:0.009480:0.010024:0.004188:0.002570:0.010009:0.008104:0.004188
physiological phenotyping on the basis of the renin and :@0.519050:0.380491:0.927974:0.380491:0.927974:0.364708:0.519050:0.364708:0.010009:0.008920:0.007801:0.005564:0.002721:0.009601:0.002721:0.009601:0.009873:0.002721:0.009480:0.010024:0.002721:0.005655:0.010009:0.008920:0.009525:0.008920:0.009601:0.004823:0.007801:0.010009:0.002721:0.008920:0.009873:0.005655:0.009601:0.008920:0.005655:0.004823:0.008920:0.009525:0.005655:0.010009:0.010024:0.005564:0.002721:0.005564:0.005655:0.009601:0.004445:0.005655:0.004823:0.008920:0.009525:0.005655:0.004248:0.009525:0.008920:0.002721:0.008920:0.005655:0.010024:0.008920:0.010357:0.004188
aldosterone profile (see Table 3). Patients with low renin/:@0.519050:0.394969:0.923877:0.394969:0.923877:0.379186:0.519050:0.379186:0.010024:0.002721:0.010054:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.008920:0.009525:0.005277:0.010009:0.004248:0.009601:0.003530:0.003530:0.002721:0.009525:0.005277:0.005277:0.005564:0.009525:0.009525:0.005277:0.006138:0.010024:0.010009:0.002721:0.009525:0.005277:0.008074:0.005277:0.003886:0.005277:0.008648:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.005277:0.012262:0.002721:0.004823:0.008920:0.005277:0.002721:0.009601:0.012262:0.005277:0.004248:0.009525:0.008920:0.002721:0.008920:0.006607
normal-to-high aldosterone receive spironolactone, those :@0.519050:0.409447:0.928020:0.409447:0.928020:0.393664:0.519050:0.393664:0.008920:0.009601:0.004248:0.013879:0.010024:0.002721:0.004717:0.004823:0.009601:0.004717:0.008920:0.002721:0.009873:0.008920:0.003750:0.010024:0.002721:0.010054:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.008920:0.009525:0.003765:0.004248:0.009525:0.009480:0.009525:0.002721:0.008074:0.009525:0.003750:0.005564:0.010009:0.002721:0.004248:0.009601:0.008920:0.009601:0.002721:0.010024:0.009480:0.004823:0.009601:0.008920:0.009525:0.003886:0.003750:0.004823:0.008920:0.009601:0.005564:0.009827:0.004188
with  low  renin/low  aldosterone  receive  amiloride  and  :@0.519050:0.423925:0.927974:0.423925:0.927974:0.408142:0.519050:0.408142:0.012262:0.002721:0.004823:0.008920:0.004188:0.004762:0.002721:0.009601:0.012262:0.004188:0.004762:0.004248:0.009525:0.008920:0.002721:0.008920:0.006305:0.002721:0.009601:0.012262:0.004188:0.004762:0.010024:0.002721:0.010054:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.008920:0.009525:0.004188:0.004762:0.004248:0.009525:0.009480:0.009525:0.002721:0.008074:0.009525:0.004188:0.004762:0.010024:0.013879:0.002721:0.002721:0.009601:0.004248:0.002721:0.010054:0.009525:0.004188:0.004762:0.010024:0.008920:0.010357:0.000000:0.004188
those with high renin/variable aldosterone receive other :@0.519050:0.438403:0.928050:0.438403:0.928050:0.422620:0.519050:0.422620:0.004823:0.008920:0.009601:0.005564:0.009525:0.005685:0.012262:0.002721:0.004823:0.008920:0.005685:0.008920:0.002721:0.009873:0.008920:0.005685:0.004248:0.009525:0.008920:0.002721:0.008920:0.006305:0.008074:0.010024:0.004248:0.002721:0.010024:0.010009:0.002721:0.009525:0.005685:0.010024:0.002721:0.010054:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.008920:0.009525:0.005685:0.004248:0.009525:0.009480:0.009525:0.002721:0.008074:0.009525:0.005685:0.009601:0.004823:0.008920:0.009525:0.004551:0.004188
antihypertensives like beta- and alpha blockers. This per-:@0.519050:0.452881:0.923786:0.452881:0.923786:0.437098:0.519050:0.437098:0.010024:0.008920:0.004823:0.002721:0.008920:0.007801:0.010009:0.009525:0.004248:0.004823:0.009525:0.008920:0.005564:0.002721:0.008074:0.009525:0.005564:0.005216:0.002721:0.002721:0.007287:0.009525:0.005216:0.010009:0.009525:0.004823:0.010024:0.004717:0.005216:0.010024:0.008920:0.010054:0.005216:0.010024:0.002721:0.010009:0.008920:0.010024:0.005216:0.010009:0.002721:0.009601:0.009480:0.007287:0.009525:0.004248:0.005564:0.003886:0.005216:0.006138:0.008920:0.002721:0.005564:0.005216:0.010009:0.009525:0.004248:0.005020
sonalised approach was confirmed to be successful in a :@0.519050:0.467359:0.928035:0.467359:0.928035:0.451576:0.519050:0.451576:0.005564:0.009601:0.008920:0.010024:0.002721:0.002721:0.005564:0.009525:0.010054:0.005140:0.010024:0.010009:0.010009:0.004248:0.009601:0.010024:0.009480:0.008920:0.005140:0.012262:0.010024:0.005564:0.005140:0.009480:0.009601:0.008920:0.003530:0.003530:0.004248:0.013879:0.009525:0.010054:0.005140:0.004823:0.009601:0.005140:0.010009:0.009525:0.005140:0.005564:0.008890:0.009480:0.009480:0.009525:0.005564:0.005564:0.004445:0.008890:0.002721:0.005140:0.002721:0.008920:0.005140:0.010326:0.004188
study done in Africa.  The main disadvantage is that pure :@0.519050:0.481837:0.928012:0.481782:0.928012:0.465999:0.519050:0.466054:0.005564:0.004823:0.008890:0.010054:0.007801:0.003689:0.010054:0.009601:0.008920:0.009525:0.003689:0.002721:0.008920:0.003689:0.010886:0.004445:0.004248:0.002721:0.009480:0.010024:0.004188:0.009048:0.003689:0.006138:0.008920:0.009525:0.003689:0.013879:0.010024:0.002721:0.008920:0.003689:0.010054:0.002721:0.005564:0.010024:0.010054:0.008074:0.010024:0.008920:0.004823:0.010024:0.009873:0.009525:0.003689:0.002721:0.005564:0.003689:0.004823:0.008920:0.010024:0.004823:0.003689:0.010009:0.008890:0.004248:0.009827:-0.224537
12:@0.662662:0.476483:0.672203:0.476483:0.672203:0.467329:0.662662:0.467329:0.004683:0.004858
amiloride is not available in south Africa and Amiloride Co :@0.519042:0.496260:0.927981:0.496260:0.927981:0.480477:0.519042:0.480477:0.010024:0.013879:0.002721:0.002721:0.009601:0.004248:0.002721:0.010054:0.009525:0.003508:0.002721:0.005564:0.003508:0.008920:0.009601:0.004823:0.003508:0.010024:0.008074:0.010024:0.002721:0.002721:0.010024:0.010009:0.002721:0.009525:0.003508:0.002721:0.008920:0.003568:0.007227:0.009601:0.008890:0.004823:0.008920:0.003508:0.010886:0.004445:0.004248:0.002721:0.009480:0.010024:0.003508:0.010024:0.008920:0.010054:0.003508:0.010886:0.013879:0.002721:0.002721:0.009601:0.004248:0.002721:0.010054:0.009525:0.003508:0.011989:0.009903:0.004188
maybe a useful alternative in half dose (see above).:@0.519042:0.510738:0.885935:0.510738:0.885935:0.494955:0.519042:0.494955:0.013879:0.010024:0.007801:0.010009:0.009525:0.003886:0.010024:0.003886:0.008890:0.005564:0.009525:0.004445:0.008890:0.002721:0.003886:0.010024:0.002721:0.004823:0.009525:0.004248:0.008920:0.010024:0.004823:0.002721:0.008074:0.009525:0.003886:0.002721:0.008920:0.003886:0.008920:0.010024:0.002721:0.004445:0.003886:0.010054:0.009601:0.005564:0.009525:0.003886:0.005277:0.005564:0.009525:0.009525:0.003886:0.010024:0.010009:0.009601:0.008074:0.009525:0.005277:0.004188
In the author’s experience, the final drug to be used if :@0.533329:0.525216:0.927966:0.525216:0.927966:0.509433:0.533329:0.509433:0.003417:0.009223:0.003991:0.005125:0.009223:0.009827:0.003991:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.005307:0.005866:0.003991:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.009827:0.009223:0.009782:0.009827:0.004188:0.003991:0.005125:0.009223:0.009827:0.003991:0.003681:0.003681:0.009223:0.010326:0.003024:0.003991:0.010357:0.004551:0.009192:0.010175:0.003991:0.005125:0.009903:0.003991:0.010311:0.009827:0.003991:0.009192:0.005866:0.009827:0.010357:0.004007:0.003024:0.004747:0.004188
all else fails, is a trial of minoxidil. This is especially useful :@0.519042:0.539694:0.927996:0.539694:0.927996:0.523911:0.519042:0.523911:0.010326:0.003024:0.003024:0.004838:0.009827:0.003024:0.005866:0.009827:0.004823:0.004747:0.010326:0.003024:0.003024:0.005866:0.004188:0.004838:0.003024:0.005866:0.004838:0.010326:0.004823:0.005125:0.004551:0.003024:0.010326:0.003024:0.004823:0.009903:0.004747:0.004823:0.014182:0.003024:0.009223:0.009903:0.007257:0.003024:0.010357:0.003024:0.003024:0.004188:0.004838:0.006441:0.009223:0.003024:0.005866:0.004823:0.003024:0.005866:0.004838:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004838:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004188
in black patients, particularly those with CKD. However, :@0.519042:0.554172:0.927981:0.554172:0.927981:0.538389:0.519042:0.538389:0.003024:0.009223:0.004430:0.010311:0.003024:0.010326:0.009782:0.007590:0.004430:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004430:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.004430:0.005125:0.009223:0.009903:0.005866:0.009827:0.004430:0.012564:0.003024:0.005125:0.009223:0.004430:0.012292:0.008935:0.011249:0.004188:0.004430:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188
unwanted hair growth – especially in females – limits its :@0.519042:0.568650:0.927966:0.568650:0.927966:0.552867:0.519042:0.552867:0.009192:0.009223:0.012564:0.010326:0.009223:0.005125:0.009827:0.010357:0.004853:0.009223:0.010326:0.003024:0.004551:0.004853:0.010175:0.004551:0.009903:0.012564:0.005125:0.009223:0.004838:0.007560:0.004853:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004868:0.003024:0.009223:0.004853:0.004747:0.009827:0.014182:0.010326:0.003024:0.009827:0.005866:0.004853:0.007560:0.004853:0.003024:0.003024:0.014182:0.003024:0.005125:0.005866:0.004868:0.003024:0.005125:0.005866:0.004188
use. A rare side effect is chemical pericarditis.:@0.519042:0.583128:0.853021:0.583128:0.853021:0.567345:0.519042:0.567345:0.009192:0.005866:0.009827:0.004188:0.004188:0.011188:0.004188:0.004551:0.010326:0.004551:0.009827:0.004188:0.005866:0.003024:0.010357:0.009827:0.004188:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.003024:0.005866:0.004188:0.009782:0.009223:0.009827:0.014182:0.003024:0.009782:0.010326:0.003024:0.004188:0.010311:0.009827:0.004551:0.003024:0.009782:0.010326:0.004551:0.010357:0.003024:0.005125:0.003024:0.005866:0.004188
neWer APPrOACHes:@0.519047:0.616322:0.704944:0.616322:0.704944:0.596157:0.519047:0.596157:0.013674:0.009609:0.016631:0.009609:0.010718:0.005174:0.013674:0.010348:0.010348:0.010718:0.015522:0.013674:0.014413:0.012566:0.009609:0.009609
There  was  initial  excitement about the use of renal :@0.519047:0.632574:0.927987:0.632574:0.927987:0.616791:0.519047:0.616791:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.004626:0.012564:0.010326:0.005866:0.004188:0.004657:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.004188:0.004657:0.009827:0.007257:0.009782:0.003024:0.005125:0.009827:0.014182:0.009827:0.009223:0.005110:0.008830:0.010326:0.010311:0.009903:0.009192:0.005125:0.008830:0.005125:0.009223:0.009827:0.008830:0.009192:0.005866:0.009827:0.008830:0.009903:0.004747:0.008830:0.004551:0.009827:0.009223:0.010326:0.003024:0.004188
denervation for the treatment of RH. Unblinded studies :@0.519047:0.647052:0.927972:0.647052:0.927972:0.631269:0.519047:0.631269:0.010357:0.009827:0.009223:0.009827:0.004551:0.008376:0.010326:0.005125:0.003024:0.009903:0.009223:0.005065:0.004747:0.009903:0.004551:0.005065:0.005125:0.009223:0.009827:0.005065:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009207:0.005125:0.005065:0.009903:0.004747:0.005065:0.009177:0.010326:0.004188:0.005065:0.009903:0.009223:0.010311:0.003024:0.003024:0.009223:0.010357:0.009827:0.010357:0.005065:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188
table 2. Common causes of secondary hypertension:@0.077030:0.677992:0.461961:0.677992:0.461961:0.661493:0.077030:0.661493:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.011793:0.009676:0.014212:0.014212:0.009676:0.009071:0.004233:0.009676:0.009979:0.009071:0.006652:0.009676:0.006652:0.004233:0.009676:0.004233:0.004233:0.006652:0.009676:0.009676:0.009676:0.009071:0.009979:0.009979:0.004838:0.008769:0.004233:0.009071:0.008769:0.009979:0.009676:0.004838:0.004536:0.009676:0.009071:0.006652:0.003629:0.009676:0.009071
Condition:@0.082070:0.696840:0.145234:0.696840:0.145234:0.682175:0.082070:0.682175:0.010483:0.008601:0.008063:0.008870:0.003225:0.004032:0.003225:0.008601:0.008063
Clinical context:@0.364050:0.696840:0.466188:0.696840:0.466188:0.682175:0.364050:0.682175:0.010483:0.003225:0.003225:0.008063:0.003225:0.008601:0.008870:0.003225:0.003763:0.008601:0.008601:0.008063:0.004032:0.008601:0.007526:0.004032
screening tests:@0.646030:0.696840:0.743598:0.696840:0.743598:0.682175:0.646030:0.682175:0.006988:0.008601:0.004301:0.008601:0.008601:0.008063:0.003225:0.008063:0.008870:0.003763:0.004032:0.008601:0.005913:0.004032:0.005913
Kidney disease:@0.082070:0.712501:0.178738:0.712501:0.178738:0.698472:0.082070:0.698472:0.007943:0.002688:0.009206:0.008198:0.008735:0.007203:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
screen all hypertensives:@0.364050:0.712501:0.519286:0.712501:0.519286:0.698472:0.364050:0.698472:0.006693:0.008695:0.004045:0.008735:0.008735:0.008198:0.003723:0.009179:0.002688:0.002688:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008735:0.008198:0.005214:0.002688:0.007445:0.008735:0.005214
Dipstick +ve for protein and/or blood, :@0.646030:0.712501:0.893391:0.712501:0.893391:0.698472:0.646030:0.698472:0.009999:0.002688:0.009165:0.005214:0.004556:0.002688:0.008695:0.006746:0.003723:0.008144:0.007445:0.008735:0.003723:0.004220:0.008803:0.004045:0.003723:0.009165:0.004045:0.008803:0.004556:0.008735:0.002688:0.008198:0.003723:0.009179:0.008198:0.009206:0.005873:0.008803:0.004045:0.003723:0.009165:0.002688:0.008803:0.008803:0.009206:0.003723:0.003723
renal ultrasound:@0.646030:0.725329:0.750829:0.725329:0.750829:0.711300:0.646030:0.711300:0.004045:0.008735:0.008198:0.009179:0.002688:0.003723:0.008171:0.002688:0.004556:0.004045:0.009179:0.005214:0.008803:0.008171:0.008198:0.009206
Renal artery stenosis – fibromuscular :@0.082070:0.740723:0.303964:0.740723:0.303964:0.726694:0.082070:0.726694:0.007754:0.008332:0.007795:0.008776:0.002285:0.003319:0.008776:0.003642:0.004153:0.008332:0.003642:0.006800:0.003319:0.004811:0.004153:0.008332:0.007795:0.008399:0.004811:0.002285:0.004811:0.003319:0.006316:0.003319:0.003071:0.003071:0.008762:0.003642:0.008399:0.012203:0.007768:0.004811:0.008292:0.007768:0.002285:0.008776:0.004045:0.003723
dysplasia, atherosclerotic, takayasu’s arteritis vasculopath or young female, CKD:@0.082070:0.753551:0.593255:0.753551:0.593255:0.739522:0.082070:0.739522:0.008803:0.006800:0.004811:0.008762:0.002285:0.008776:0.004811:0.002285:0.008776:0.003319:0.003252:0.008776:0.004153:0.007795:0.008332:0.003642:0.008399:0.004811:0.008292:0.002285:0.008332:0.003642:0.008399:0.004153:0.002285:0.008292:0.003319:0.003252:0.004153:0.008776:0.006343:0.008776:0.006800:0.008776:0.004811:0.007768:0.004314:0.004811:0.003252:0.008776:0.003642:0.004153:0.008332:0.003642:0.002285:0.004153:0.002285:0.005214:0.010079:0.007445:0.009179:0.005214:0.008695:0.008171:0.002688:0.008803:0.009165:0.009179:0.004556:0.008198:0.003723:0.008803:0.004045:0.003723:0.007203:0.008803:0.008171:0.008198:0.009045:0.003723:0.004220:0.008735:0.012606:0.009179:0.002688:0.008735:0.003723:0.003723:0.010926:0.007943:0.009999
Bruits, discrepant pulses in older :@0.364050:0.740723:0.572007:0.740723:0.572007:0.726694:0.364050:0.726694:0.007714:0.004045:0.008171:0.002688:0.004556:0.005214:0.003723:0.003723:0.009206:0.002688:0.005214:0.008695:0.004045:0.008735:0.009165:0.009179:0.008198:0.004556:0.003723:0.009165:0.008171:0.002688:0.005214:0.008735:0.005214:0.003723:0.002688:0.008198:0.003723:0.008803:0.002688:0.009206:0.008735:0.004045:0.003723
Kidney ultrasound, captopril renogram, :@0.646030:0.740723:0.904210:0.740723:0.904210:0.726694:0.646030:0.726694:0.007943:0.002688:0.009206:0.008198:0.008735:0.007203:0.003723:0.008171:0.002688:0.004556:0.004045:0.009179:0.005214:0.008803:0.008171:0.008198:0.009206:0.003723:0.003723:0.008695:0.009179:0.009165:0.004556:0.008803:0.009165:0.004045:0.002688:0.002688:0.003723:0.004045:0.008735:0.008198:0.008803:0.009045:0.004045:0.009179:0.012606:0.003723:0.003723
CT angiography:@0.646030:0.753551:0.751151:0.753551:0.751151:0.739522:0.646030:0.739522:0.010926:0.005725:0.003723:0.009179:0.008198:0.009045:0.002688:0.008803:0.009045:0.004045:0.009179:0.009165:0.008198:0.007203
phaeochromocytoma:@0.082070:0.768945:0.227132:0.768945:0.227132:0.754916:0.082070:0.754916:0.007956:0.008198:0.009179:0.008735:0.008803:0.008695:0.008198:0.004045:0.008803:0.012606:0.008803:0.008695:0.007203:0.004556:0.008803:0.012606:0.009179
sweating, palpations, headaches, labile :@0.364050:0.768945:0.629688:0.768945:0.629688:0.754916:0.364050:0.754916:0.006693:0.011168:0.008735:0.009179:0.004556:0.002688:0.008198:0.009045:0.003723:0.003723:0.009165:0.009179:0.002688:0.009165:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.003723:0.008198:0.008735:0.009179:0.009206:0.009179:0.008695:0.008198:0.008735:0.005214:0.003723:0.003723:0.002688:0.009179:0.009165:0.002688:0.002688:0.008735:0.003723
Bp, weight loss (rare if symptoms absent):@0.364050:0.781774:0.625334:0.781774:0.625334:0.767745:0.364050:0.767745:0.007714:0.007956:0.003723:0.003723:0.011168:0.008735:0.002688:0.009045:0.008198:0.004556:0.003723:0.002688:0.008803:0.005214:0.005214:0.003723:0.004959:0.004045:0.009179:0.004045:0.008735:0.003723:0.002688:0.004220:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.009179:0.009165:0.005214:0.008735:0.008198:0.004556:0.004959
24-hour nor-meta-adrenaline:@0.646030:0.768945:0.834219:0.768945:0.834219:0.754916:0.646030:0.754916:0.007445:0.007445:0.004462:0.008198:0.008803:0.008171:0.004045:0.003723:0.008198:0.008803:0.004045:0.004462:0.012606:0.008735:0.004556:0.009179:0.004462:0.009179:0.009206:0.004045:0.008735:0.008198:0.009179:0.002688:0.002688:0.008198:0.008735
primary aldosteronism:@0.082070:0.797168:0.223450:0.797168:0.223450:0.783139:0.082070:0.783139:0.007956:0.004045:0.002688:0.012606:0.009179:0.004045:0.007203:0.003723:0.009179:0.002688:0.009206:0.008803:0.005214:0.004556:0.008735:0.004045:0.008803:0.008198:0.002688:0.005214:0.012606
Resistant hypertension or low K:@0.364050:0.797168:0.562627:0.797168:0.562627:0.783139:0.364050:0.783139:0.008158:0.008735:0.005214:0.002688:0.005214:0.004556:0.009179:0.008198:0.004556:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008735:0.008198:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004045:0.003723:0.002688:0.008803:0.011168:0.003723:0.007943
+:@0.562605:0.786040:0.567329:0.786040:0.567329:0.777903:0.562605:0.777903:0.004724
Low K , aldosterone renin ratio (ratio :@0.646029:0.797164:0.884451:0.797164:0.884451:0.783135:0.646029:0.783135:0.006209:0.008803:0.011168:0.003723:0.007943:0.004716:0.003723:0.003723:0.009179:0.002688:0.009206:0.008803:0.005214:0.004556:0.008735:0.004045:0.008803:0.008198:0.008735:0.003723:0.004045:0.008735:0.008198:0.002688:0.008198:0.003723:0.004045:0.009179:0.004556:0.002688:0.008803:0.003723:0.004959:0.004045:0.009179:0.004556:0.002688:0.008803:0.003723
+:@0.683866:0.792454:0.688590:0.792454:0.688590:0.784317:0.683866:0.784317:0.004724
>70, and aldosterone >500 pmol/L highly :@0.646028:0.809992:0.913708:0.809992:0.913708:0.795963:0.646028:0.795963:0.008144:0.007445:0.007445:0.003723:0.003723:0.009179:0.008198:0.009206:0.003723:0.009179:0.002688:0.009206:0.008803:0.005214:0.004556:0.008735:0.004045:0.008803:0.008198:0.008735:0.003723:0.008144:0.007445:0.007445:0.007445:0.003723:0.009165:0.012606:0.008803:0.002688:0.005873:0.006209:0.003723:0.008198:0.002688:0.009045:0.008198:0.002688:0.007203:0.003723
suggestive):@0.646028:0.822820:0.719835:0.822820:0.719835:0.808791:0.646028:0.808791:0.005214:0.008171:0.009045:0.009045:0.008735:0.005214:0.004556:0.002688:0.007445:0.008735:0.004959
Liddle syndrome:@0.082067:0.838214:0.188532:0.838214:0.188532:0.824185:0.082067:0.824185:0.006209:0.002688:0.009206:0.009206:0.002688:0.008735:0.003723:0.005214:0.007203:0.008198:0.009206:0.004045:0.008803:0.012606:0.008735
Resistant hypertension or low K:@0.364047:0.838214:0.562624:0.838214:0.562624:0.824185:0.364047:0.824185:0.008158:0.008735:0.005214:0.002688:0.005214:0.004556:0.009179:0.008198:0.004556:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008735:0.008198:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004045:0.003723:0.002688:0.008803:0.011168:0.003723:0.007943
+:@0.562605:0.833504:0.567329:0.833504:0.567329:0.825368:0.562605:0.825368:0.004724
Low K , renin and aldosterone:@0.646029:0.838214:0.840089:0.838214:0.840089:0.824185:0.646029:0.824185:0.006209:0.008803:0.011168:0.003723:0.007943:0.004716:0.003723:0.003723:0.004045:0.008735:0.008198:0.002688:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.009179:0.002688:0.009206:0.008803:0.005214:0.004556:0.008735:0.004045:0.008803:0.008198:0.008735
+:@0.683866:0.833504:0.688590:0.833504:0.688590:0.825368:0.683866:0.825368:0.004724
sleep apnoea:@0.082067:0.853608:0.175066:0.853608:0.175066:0.839579:0.082067:0.839579:0.006693:0.002688:0.008735:0.008735:0.009165:0.003723:0.009179:0.009165:0.008198:0.008803:0.008735:0.009179
snoring, day-time somnolence, obesity:@0.364047:0.853608:0.616005:0.853608:0.616005:0.839579:0.364047:0.839579:0.006693:0.008198:0.008803:0.004045:0.002688:0.008198:0.009045:0.003723:0.003723:0.009206:0.009179:0.007203:0.004462:0.004556:0.002688:0.012606:0.008735:0.003723:0.005214:0.008803:0.012606:0.008198:0.008803:0.002688:0.008735:0.008198:0.008695:0.008735:0.003723:0.003723:0.008803:0.009165:0.008735:0.005214:0.002688:0.004556:0.007203
Refer:@0.646028:0.853608:0.679921:0.853608:0.679921:0.839579:0.646028:0.839579:0.008158:0.008735:0.004220:0.008735:0.004045
Thyroid disease:@0.082067:0.869002:0.180630:0.869002:0.180630:0.854973:0.082067:0.854973:0.005725:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
symptoms and signs of hypo- or :@0.364047:0.869002:0.573873:0.869002:0.573873:0.854973:0.364047:0.854973:0.006693:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.009179:0.008198:0.009206:0.003723:0.005214:0.002688:0.009045:0.008198:0.005214:0.003723:0.008803:0.004220:0.003723:0.008198:0.007203:0.009165:0.008803:0.004462:0.003723:0.008803:0.004045:0.003723
hyperthyroidism:@0.364047:0.881830:0.466602:0.881830:0.466602:0.867801:0.364047:0.867801:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606
TsH:@0.646028:0.869002:0.667624:0.869002:0.667624:0.854973:0.646028:0.854973:0.005725:0.006693:0.009179
parathyroid disease:@0.082067:0.897224:0.209820:0.897224:0.209820:0.883195:0.082067:0.883195:0.007956:0.009179:0.004045:0.009179:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
Rare:@0.364047:0.897224:0.394165:0.897224:0.394165:0.883195:0.364047:0.883195:0.008158:0.009179:0.004045:0.008735
Calcium, pTH:@0.646028:0.897224:0.731285:0.897224:0.731285:0.883195:0.646028:0.883195:0.010926:0.009179:0.002688:0.008695:0.002688:0.008171:0.012606:0.003723:0.003723:0.007956:0.005725:0.009179
Cushing’s syndrome:@0.082067:0.912618:0.212172:0.912618:0.212172:0.898589:0.082067:0.898589:0.010926:0.008171:0.005214:0.008198:0.002688:0.008198:0.009045:0.004717:0.005214:0.003723:0.005214:0.007203:0.008198:0.009206:0.004045:0.008803:0.012606:0.008735
Rapid weight gain, features of Cushing’s:@0.364047:0.912618:0.626527:0.912618:0.626527:0.898589:0.364047:0.898589:0.008158:0.009179:0.009165:0.002688:0.009206:0.003723:0.011168:0.008735:0.002688:0.009045:0.008198:0.004556:0.003723:0.009045:0.009179:0.002688:0.008198:0.003723:0.003723:0.004220:0.008735:0.009179:0.004556:0.008171:0.004045:0.008735:0.005214:0.003723:0.008803:0.004220:0.003723:0.010926:0.008171:0.005214:0.008198:0.002688:0.008198:0.009045:0.004717:0.005214
24-hour urine cortisol:@0.646028:0.912618:0.779371:0.912618:0.779371:0.898589:0.646028:0.898589:0.007445:0.007445:0.004462:0.008198:0.008803:0.008171:0.004045:0.003723:0.008171:0.004045:0.002688:0.008198:0.008735:0.003723:0.008695:0.008803:0.004045:0.004556:0.002688:0.005214:0.008803:0.002688
Coarctation of the aorta:@0.082067:0.928012:0.243135:0.928012:0.243135:0.913983:0.082067:0.913983:0.010926:0.008803:0.009179:0.004045:0.008695:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.008735:0.003723:0.009179:0.008803:0.004045:0.004556:0.009179
Young hypertensive with radio-femoral :@0.364047:0.928012:0.619297:0.928012:0.619297:0.913983:0.364047:0.913983:0.007956:0.008803:0.008171:0.008198:0.009045:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008735:0.008198:0.005214:0.002688:0.007445:0.008735:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.004462:0.004220:0.008735:0.012606:0.008803:0.004045:0.009179:0.002688:0.003723
delay:@0.364047:0.940840:0.401059:0.940840:0.401059:0.926811:0.364047:0.926811:0.009206:0.008735:0.002688:0.009179:0.007203
Chest radiograph, echocardiography:@0.646028:0.928012:0.892260:0.928012:0.892260:0.913983:0.646028:0.913983:0.010926:0.008198:0.008735:0.005214:0.004556:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.009045:0.004045:0.009179:0.009165:0.008198:0.003723:0.003723:0.008735:0.008695:0.008198:0.008803:0.008695:0.009179:0.004045:0.009206:0.002688:0.008803:0.009045:0.004045:0.009179:0.009165:0.008198:0.007203